Kiora Pharmaceuticals Inc...

NASDAQ: KPRX · Real-Time Price · USD
2.93
0.40 (15.81%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.71%
After-hours: Aug 15, 2025, 07:12 PM EDT

Kiora Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-11.98M -12.05M 3.59M 5.55M 3.2M 2.81M -12.51M -12.74M -12.1M -11.89M -13.58M -19.46M -17.31M -17.38M -16.39M -10.43M -9.47M -8.72M
Depreciation & Amortization
42.51K 56.97K 53.57K 44.12K 53.33K 57.93K 51.8K 54.15K 53.11K 40.91K 41.61K 42.36K 43.15K 45.47K 45.3K 43.32K 40.9K 36.93K
Stock-Based Compensation
742.75K 629.77K 656.59K 678.76K 772.45K 794.45K 754.94K 617.72K 483.01K 382.47K 462.45K 630.5K 649.81K 841.45K 842.48K 822.46K 860.72K 794.88K
Other Working Capital
1.26M 1.61M 2.41M -73.32K -190.43K 1.2M 1.68M 2.12M 2.27M 192.72K -79.4K -879.38K -751.33K -362.77K -725.13K -85.14K -377.63K 13.38K
Other Non-Cash Items
1.25M 1.14M 876.91K 911.46K 1.59M 1.72M 1.98M 1.92M 2.17M 2.06M 2.1M 7.97M 6.22M 6.2M 5.96M 175.44K 169.28K 164.87K
Deferred Income Tax
-288.75K -288.75K -288.75K 90.32K 1.99M 1.99M 1.99M 1.79M -113.01K -113.01K -113.01K -304.78K -304.78K -304.78K -304.78K 12.05K 12.05K 12.05K
Change in Working Capital
2.4M 2.74M 3.67M 955.85K -2.83M -240.98K -1.82M -745.17K -39.89K -1.15M 668.51K -579.56K -312.66K -554.38K -1.04M 192.44K -267.38K 224.92K
Operating Cash Flow
-7.84M -7.77M 8.56M 8.23M 4.79M 7.14M -9.56M -9.1M -9.55M -10.67M -10.43M -11.71M -11.01M -11.15M -10.89M -9.19M -8.66M -7.49M
Capital Expenditures
12.84K -6.25K -6.25K -51.28K -51.28K 2.00 -3 -3 n/a n/a n/a 63.87K 63.87K 58.12K n/a -83.94K -83.94K -78.2K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.38K -86.78K -86.78K -86.78K -93.16K -110.64K -110.64K -110.64K
Purchase of Investments
-22.52M -39.25M -35.63M -29.09M -21.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
24.41M 19.27M 12.98M 6M 115.65K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -236 -236 -236 -236 6.38K 6.38K 6.38K 12.75K -57.49K -57.49K -57.49K -63.87K -113.72K -113.72K -113.72K
Investing Cash Flow
1.9M -19.99M -22.66M -23.15M -21.23M -236 -236 6.38K 6.38K 6.38K 12.75K -86.78K -86.78K -92.53K -157.02K -308.3K -806.99K -801.24K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 278.19K 278.19K 278.19K 278.19K n/a n/a n/a
Common Stock Repurchased
n/a 1.19M n/a n/a n/a -1.19M n/a -15.63K -15.63K -15.63K -15.63K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
15M 14.06M 15.5M 817.61K 1.63M 1.76M 616.82K 3.56M 2.24M 3.05M 2.75M -1.51M -1M -1.28M -1.23M -10.19K -10.19K 546.19K
Financial Cash Flow
265.36K 250.52K 15.5M 15.01M 15.01M 20.7M 5.97M 9.7M 15.07M 9.13M 8.62M 5.66M 10.03M 9.76M 17.8M 17.74M 8.48M 9.03M
Net Cash Flow
-5.55M -27.51M 1.34M 236.86K -1.38M 27.85M -3.56M 553.88K 5.48M -1.68M -1.89M -6.3M -1.23M -1.54M 6.67M 8.18M -1.03M 732.51K
Free Cash Flow
-7.83M -7.78M 8.55M 8.18M 4.74M 7.14M -9.56M -9.1M -9.55M -10.67M -10.43M -11.65M -10.95M -11.09M -10.89M -9.27M -8.74M -7.57M